MiNK Therapeutics (INKT) Insider Trading & Ownership $7.62 +0.43 (+5.90%) Closing price 07/9/2025 02:49 PM EasternExtended Trading$7.33 -0.30 (-3.92%) As of 07/9/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiNK Therapeutics (NASDAQ:INKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.48%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$667.93KNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$95.00K Get INKT Insider Trade Alerts Want to know when executives and insiders are buying or selling MiNK Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INKT Insider Buying and Selling by Quarter MiNK Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/16/2023Agenus IncMajor ShareholderBuy42$11.00$462.00 10/12/2023Agenus IncMajor ShareholderBuy317$11.00$3,487.00 10/4/2023Agenus IncMajor ShareholderBuy1,500$10.90$16,350.00 8/28/2023Agenus IncMajor ShareholderBuy1,280$14.50$18,560.00 8/24/2023Agenus IncMajor ShareholderBuy17,024$15.40$262,169.60 5/10/2023Agenus IncMajor ShareholderBuy2,206$15.10$33,310.60 5/5/2023Agenus IncMajor ShareholderBuy10,020$9.50$95,190.00 5/5/2023Garo H ArmenDirectorSell10,000$9.50$95,000.00 5/3/2023Agenus IncMajor ShareholderBuy12,868$10.80$138,974.40 5/2/2023Garo H ArmenDirectorBuy10,000$9.50$95,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/18/2022Ulf WiinbergDirectorBuy333$13.30$4,428.90 (Data available from 1/1/2013 forward) INKT Insider Trading Activity - Frequently Asked Questions Who is on MiNK Therapeutics' Insider Roster? The list of insiders at MiNK Therapeutics includes Agenus Inc, Garo H Armen, and Ulf Wiinberg. Learn more on insiders at INKT. What percentage of MiNK Therapeutics stock is owned by insiders? 22.48% of MiNK Therapeutics stock is owned by insiders. Learn more on INKT's insider holdings. Which MiNK Therapeutics insiders have been buying company stock? The following insider purchased INKT shares in the last 24 months: Agenus Inc ($301,028.60). How much insider buying is happening at MiNK Therapeutics? Insiders have purchased a total of 20,163 INKT shares in the last 24 months for a total of $301,028.60 bought. MiNK Therapeutics Key ExecutivesDr. Garo H. Armen Ph.D. (Age 71)Executive Chairman Dr. Jennifer S. Buell Ph.D. (Age 48)President, CEO & Director Compensation: $916.75kDr. Marcus Antonius van Dijk Ph.D. (Age 62)Chief Scientific Officer Compensation: $458.28kMs. Christine M. Klaskin (Age 58)Treasurer Compensation: $29.62kJoy Zhou Ph.D.Vice President & Head of CMC More Insider Trading Tools from MarketBeat Related Companies Genelux Insider Buying Protara Therapeutics Insider Buying Atossa Genetics Insider Buying TuHURA Biosciences Insider Buying C4 Therapeutics Insider Buying Anixa Biosciences Insider Buying Milestone Pharmaceuticals Insider Buying Seres Therapeutics Insider Buying HilleVax Insider Buying Jasper Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Do They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold? This page (NASDAQ:INKT) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INKT Stock Alerts